ANA TURNER: Open Payments
NPI 1881318251 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,926 in 132 payments from 18 companies in 2025. Trend: 2023 $481 · 2024 $3,487 · 2025 $3,926
Food & beverage: $3,837Education: $89
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $740 |
| ABBVIE INC. | 21 | $483 |
| Lilly USA, LLC | 10 | $357 |
| Madrigal Pharmaceuticals | 13 | $303 |
| Phathom Pharmaceuticals, Inc. | 4 | $240 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $228 |
| QOL Medical, LLC | 8 | $224 |
| GENZYME CORPORATION | 5 | $218 |
| Regeneron Healthcare Solutions, Inc. | 3 | $207 |
| Aimmune Therapeutics, Inc. | 5 | $182 |
Products named: TREMFYA, DUPIXENT, OMVOH, REZDIFFRA, VOQUEZNA, Sucraid, XIFAXAN, RINVOQ.
Industry payments across NV — which companies pay providers there.
